Last Updated : August 15, 2014
Details
FilesGeneric Name:
Taliglucerase alfa
Project Status:
Complete
Therapeutic Area:
Gaucher disease
Manufacturer:
Pfizer Canada Inc.
Call for patient/clinician input open:
Brand Name:
Elelyso
Project Line:
Reimbursement Review
Project Number:
SR0390-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Gaucher disease
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : August 15, 2014